- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03210415
Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old
October 27, 2019 updated by: Hongbo Qi, Ministry of Science and Technology of the People´s Republic of China
In China, there's no effective prevention and treatment on preterm birth for pregnant women ≥35 years old, so this study is necessary.
Study Overview
Detailed Description
Because the policy of "Two-child" in China, there are more and more women more than 35 years old choose to have another baby.
It is necessary to find out a way to prevent them who is older than 35 from preterm labor.
About 1500 pregnant women will be recruited at about gestational age of 14 weeks for this study.
All of them will be taken samples (i.e.
blood, hair, cervical secretion ) to be saved before and after delivery.
After all data collected, the investigators will do analysis of all data and find out strategy and mechanism of preterm labor.
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 400010
- The First Affilliated Hospital of Chongqig Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Chinese pregnant women ≥ 35 years old with spontaneous preterm birth between 28-37 weeks of gestation.
Description
Inclusion Criteria:
- Chinese pregnant women ≥ 35 years old
Exclusion Criteria:
- twins or multiple pregnancies, indicated preterm birth, <35 years old, gestational ages ≥ 37 weeks, incomplete data of prenatal care。
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Study group
Pregnant women ≥35 years old would have spontaneous preterm labor.
There's no intervention in this group, because it's an Observational Study Model.
|
There is no intervention for the study.
|
Control group
Pregnant women ≥35 years old would not have spontaneous preterm labor.
There's no intervention in this group, because it's an Observational Study Model.
|
There is no intervention for the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Morbidity of Preterm birth
Time Frame: 1 years
|
Preterm delivery (PTD) is one of the most common and most serious complications of pregnancy.
In China, preterm delivery is defined as delivery after 28 weeks completed but before 37 weeks of gestation.
PTD rate varies between 5-18 %.
Outcome also varies with the quality of neonatal care.
create the highest burden for the society.
|
1 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Burden
Time Frame: 1 years
|
Outcome varies with the quality of neonatal care.
create the highest burden for the society.
A 2006 report from the Institute of Medicine estimated the annual cost of preterm birth in the United States to be $26.2 billion or more than $51,000 per premature infant .
|
1 years
|
Morbidity of Chorioamnionitis
Time Frame: 1 years
|
The main hypothesis of the etiology of spontaneous PTD is ascending infection from the lower genital tract up in the sterile uterus invading the decidua, chorioamniotic membranes, amniotic fluid and, in some cases, the fetus.
This is responsible for an inflammatory condition that might trigger myometrial contractions, rupture of the membranes and cervical maturation leading to PTD.
Investigations have shown that the amount of bacteria present in the amniotic fluid is correlated to the level of intrauterine inflammation.
Inflammation is also related to the presence of bacteria in the amniotic fluid and to histological chorioamnionitis.
|
1 years
|
Respiratory distress syndrome, ischemic hypoxic encephalopathy, necrotizing enterocolitis, various infections
Time Frame: 1 years
|
the short-term outcomes of the preterm delivery, which will cost money, time and source to beat.
The treatment is not satisfactory, but create the highest burden for the society.
|
1 years
|
Cerebral palsy, chronic lung disease, blindness caused by retinopathy, auditory nerve abnormalities, mental retardation
Time Frame: 1 years
|
the long-term outcomes of the preterm delivery.
The main areas that are affected are the respiratory function and the neurodevelopment of these babies due to the early arrest in the lung and brain development, respectively.
Moreover, the overall general health of this population is affected in the long-term and ongoing follow up studies are required to provide a better understanding in the field.
|
1 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Hongbo bo Qi, Dr., First Affiliated Hospital of Chongqing Medical University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2017
Primary Completion (Anticipated)
June 30, 2020
Study Completion (Anticipated)
December 30, 2020
Study Registration Dates
First Submitted
May 4, 2017
First Submitted That Met QC Criteria
July 3, 2017
First Posted (Actual)
July 7, 2017
Study Record Updates
Last Update Posted (Actual)
October 29, 2019
Last Update Submitted That Met QC Criteria
October 27, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016YFC1000407
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Labor
-
Istanbul University - Cerrahpasa (IUC)CompletedPreterm Labor | Preterm Spontaneous Labor With Preterm Delivery | Preterm Labor With Preterm Delivery in Third TrimesterTurkey
-
University Hospital, Strasbourg, FranceRecruitingPreterm Delivery | Threatened Preterm LaborFrance
-
Ain Shams UniversityRecruitingPreterm Labor With Preterm DeliveryEgypt
-
University of Modena and Reggio EmiliaNot yet recruitingPreterm Labor With Preterm DeliveryItaly
-
PreTeL, IncDuke University; University of RochesterRecruitingPreterm Birth | Threatened Preterm Labor | PreTerm LaborUnited States
-
Konya Meram State HospitalRecruitingPregnancy Preterm | Preterm Labor Without DeliveryTurkey
-
e-Bio CorpRecruitingPreterm Labor | PreTerm Birth | Preterm Labor With Delivery NosUnited States
-
Hospital Clinico Universitario de SantiagoFundación Ramón DomínguezWithdrawnThreatened Preterm Labor
-
Tel-Aviv Sourasky Medical CenterUnknownLabor Preterm Multiple
-
Shiraz University of Medical SciencesCompletedManaging Preterm Labor
Clinical Trials on Observational Study Model
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH)CompletedSchizophrenia | BipolarUnited States
-
Taysha Gene Therapies, Inc.Withdrawn
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States
-
University of ManitobaCompletedObesity | Pregnancy | Cesarean SectionCanada
-
University of Castilla-La ManchaRecruitingKnee OsteoarthritisSpain
-
AstraZenecaRecruiting
-
Drexel UniversityCompletedOsteoporosisUnited States
-
The Aurum Institute NPCKarolinska Institutet; Ludwig-Maximilians - University of Munich; University... and other collaboratorsUnknownRespiratory Tract Infections | Tuberculosis, PulmonaryMozambique, South Africa, Tanzania, Gambia
-
Oslo University HospitalThe Research Council of NorwayRecruitingMesothelioma | Pseudomyxoma Peritonei | Colorectal Carcinoma | Ovarian CarcinomaNorway
-
Oslo University HospitalThe Research Council of NorwayActive, not recruiting